RECRUITING

A 48 Week Observational Study of the Frequency of Symptomatic Herpes Virus I and II in HIV Infected Subjects

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study is an observational, cohort, prospective study looking at the frequency of Herpes Simplex Virus (HSV) 1 and or 2 outbreaks in HIV positive patients who's HIV virus is controlled on highly active anti-retroviral therapy. We will be enrolling fifty (50) patients.

Official Title

A 48 Week Observational Study of the Frequency of Symptomatic Herpes Virus I and II in HIV Infected Subjects

Quick Facts

Study Start:2022-04-01
Study Completion:2025-04-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05823779

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Subject must be 18 years or older at the time of screening
  2. 2. Males, Females, Transgender Male and Transgender Females
  3. 3. HIV positive
  4. 4. Positive antibody to HSV- 1/and or HSV-2
  5. 5. If Female of child baring potential, documented negative pregnancy test at the time of screening.
  1. 1. Active opportunistic infection
  2. 2. Current chemotherapy
  3. 3. Unable to give informed consent

Contacts and Locations

Study Contact

Jorge E Rodriguez, M.D.
CONTACT
(323) 934-3690
2jrodmd@gmail.com
Michael S Gottlieb, M.D.
CONTACT
(323) 215-1725
drmichael.gottlieb@gmail.com

Study Locations (Sites)

Global Research Institute
Los Angeles, California, 90036
United States

Collaborators and Investigators

Sponsor: Global Research Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-04-01
Study Completion Date2025-04-01

Study Record Updates

Study Start Date2022-04-01
Study Completion Date2025-04-01

Terms related to this study

Keywords Provided by Researchers

  • HIV, Herpes Simplex 1, Herpes Simplex 2

Additional Relevant MeSH Terms

  • HIV Disease
  • Herpes Simplex 1
  • Herpes Simplex 2